Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03160963 · ClinicalTrials.gov registry record
Clinical Power Testing Across Human Lifetime
A clinical trial, sponsored by University of Miami.
- Completed
- Registry status
- 70
- Enrollment target
NCT03160963: Completed study, sponsored by University of Miami.
NCT03160963 is a clinical trial that has completed, run by University of Miami. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03160963 has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
Study Summary
We will determine when to transition from the common vertical jump to chair stand depending on age and physical activity levels.
Primary Outcome
The subject will alternate standing a sitting as many times as possible in the 30 second time frame. Wattage (power) will be computed using the equation by Smith et al., Clin Interventions on Aging, 2010.
Interventions
- OTHER Power Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2017-01-25 |
| Est. Completion | 2019-08-15 |
What the finished NCT03160963 record still lists
NCT03160963 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 70 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Power Testing is the first listed.
NCT03160963 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03160963 about?
NCT03160963 is a clinical study titled "Clinical Power Testing Across Human Lifetime". We will determine when to transition from the common vertical jump to chair stand depending on age and physical activity levels.
What is the current status of trial NCT03160963?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2017-01-25. Estimated completion is 2019-08-15.
What interventions are being tested in trial NCT03160963?
The interventions under investigation include: Power Testing (OTHER).
Who is sponsoring clinical trial NCT03160963?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI